Increasing incidence of thyroid cancer in Puerto Rico, 1985-2004

Puerto Rico Health Sciences Journal

Volumn 30, Issue 3, 2011, Pages 109-115

  Ramírez Vick, Margarita ^a   Nieves Rodríguez, Mariela ^a   Lúgaro Gómez, Ana ^a   Pérez Irizarry, Javier ^b  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

Epidemiology; Incidence; Mortality; Puerto rico; Thyroid cancer

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; FEMALE; HUMAN; INCIDENCE; INFANT; MALE; MIDDLE AGED; PRESCHOOL CHILD; PUERTO RICO; RETROSPECTIVE STUDY; THYROID TUMOR; TIME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; PUERTO RICO; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; TIME FACTORS; YOUNG ADULT;

EID: 80052433134     PISSN: 07380658     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Franceschi S, Boyle P, Maisonneuve P, et al. The epidemiology of thyroid carcinoma. Crit Rev Oncog 1993;4:25-52.
2. Miller BA, Ries LAG, Hankey BF, et al, eds. SEER Cancer Statistics Review: 1973-1990. Bethesda, MD: National Cancer Institute. NIH Publications; 1993. No. 93-2789.
3. Torres-Cintron M, Ortiz AP, Perez-Irizarry J, et al. Incidence and mortality of the leading cancers types in Puerto Rico: 1987-2004. P R Health Sci J 2010;29:317-329.
4. Lui S, Semenciw R, Ugnat A-M, Mao Y. Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period cohort effects. Br J Cancer 2001;85:1335-1339.
5. Davies L, Welch HG. Increasing Incidence of Thyroid Cancer in the United States, 1973-2002. JAMA 2006;295:2164-2167.
6. Enewold L, Zhu K, Ron E, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev 2009;18:784-791.
7. Leenhardt L, Grosclaude P, Cherie-Challine L. Thyroid Cancer Committee Increased Incidence of Thyroid Carcinoma in France: A True Epidemic or Thyroid Nodule Management Effects? Report from the French Thyroid Cancer Committee. Thyroid 2004;14:1056-1060.
8. Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2008. National Cancer Institute. Bethesda, MD. Available at: Url: http://seer.cancer.gov/csr/1975_2008/, based on November 2010 SEER data submission, posted to the SEER web site, 2011.
9. Kent WDT, Hall SF, Isotalo PA, et al. Increased incidence of differentiated thyroid cancer and detection of subclinical disease. CMAJ 2007;177:1357-1361.
10. Yu GP, Li JC, Branovan D, McCormick S, Schantz SP. Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups. Thyroid 2010;20: 465-473.
11. Fuentes R. Cancer of the thyroid gland in Puerto Rico. Bol Asoc Med P R 1952;44:370-372.
12. Martinez I. Cancer en Puerto Rico. Departamento de Salud, Estado Libre Asociado de Puerto Rico, 1975; 78.
13. Ydrach AA, Marcial VA, Velazquez Vera J, Moscol JA. Undifferentiated carcinoma of the thyroid: case reports and review of the PR Cancer registry experience from 1970-1974. Bol Asoc Med PR, 1980;72: 353-359.
14. Munoz MB and Sorrentino R. Carcinoma of the thyroid at the University (District) Hospital. Bol Asoc Med P R 1965;57:346-350.
15. Puerto Rico Central Cancer Registry. Comprehensive Center Cancer of the University of Puerto Rico. Incidence Case File (December 2010), Division of Epidemiology, PR Department of Health.
16. Fritz A, Jack A, Percy C, Parkin M, Sobin L. International Classification of Diseases for Oncology, 3rd Edition. Geneva, Switzerland. World Health Organization; 2000.
17. National Cancer Institute Surveillance Research Program. SEER Incidence Site Recode ICD-O-3 (1/27/2003) Definition. US National Institutes of Health, Bethesda, Maryland.
18. Puerto Rico Mortality File. Puerto Rico Department of Health: Division of Statistical Analysis, Auxiliary Secretariat for Planning and Development, 2010.
19. SEER* Stat software (www.seer.cancer.gov/seerstat) version 6.4.4. [computer program]. Version 6.4.4.
20. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000;19:335-351.
21. Marrett LD, De P, Airia P, Dryer D. Steering Committee of Canadian Cancer Statistics 2008. Cancer in Canada in 2008. CMAJ 2008; 179:1163-1170.
22. Burgess JR, Tucker P. Incidence Trends for Papillary Thyroid Carcinoma and Their Correlation with Thyroid Surgery and Thyroid Fine-Needle Aspirate Cytology. Thyroid 2006;16:47-53.
23. Hanford JM, Quimby EH, Frantz VK. Cancer arising many years after radiation therapy. Incidence after irradiation of benign lesions in the neck. JAMA 1962;181:404-410.
24. Janower ML, Miettinen OS. Neoplasms after childhood irradiation of the thymus gland. JAMA 1971;215:753-756.
25. Stezhko VA, Buglova EE, Danilova LI, et al. A cohort study of thyroid cancer and other thyroid diseases after the Chernobyl accident: objectives, design and methods. Radiat Res 2004;161:481-492.
26. Wartofsky L. Increasing world incidence of thyroid cancer: Increased detection or higher radiation exposure? Hormones (Athens) 2010;9:103-108.
27. Sinnott B, Ron E, Schneider AB. Exposing the thyroid to radiation: a review of its current extent, risks, and implications. Endocr Rev 2010;31:756-773.
28. Guan H, Ji M, Bao R, et al. Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer. J Clin Endocrinol Metab. 2009;94:1612-1617.
29. Patel KN, Singh B. Genetic considerations in thyroid cancer. Cancer Control 2006;13:111-118.
30. Harach HR, Escalante DA, Onativia A, et al. Thyroid carcinoma and thyroiditis in an endemic goiter region before and after iodine prohylaxis. Acta Endocrinol (Copenh)1985;108:55-60.
31. Knobel M, Medeiros-Neto G. Relevance of iodine intake as a reputed predisposing factor for thyroid cancer. Arq Bras Endocrinol Metabol 2007;51:701-712.
32. Lind P, Langsteger W, Molnar M, Gallowitsch HJ, Mikosch P, Gomez I. Epidemiology of thyroid diseases in iodine sufficiency. Thyroid 1998;8:1179-1183.
33. Langsteger W, Koltringer P, Wolf G, et al. The impact of geographical, clinical, dietary and radiation-induced features in the epidemiology of thyroid cancer. Eur J Cancer 1993;29A:1547-1553.
34. Hedinger CE, Williams ED, Sobin LH. Histological typing of thyroid tumors (histological classification of tumors, no. 11), 2nd ed. World Health Organization International. Berlin, Germany: Springer Verlag; 1988.
35. Rojeski MT, Gharib H. Nodular thyroid disease. Evaluation and management. N Engl J Med 1985;313:428-436.
36. Ortiz AP, Harlow S, Sowers M, Romaguera J. Age at natural menopause in a sample of Puerto Rican women. P R Health Sci J 2003;22:337-342.
37. Preston-Martin S, Bernstein L, Pike MC, et al. Thyroid Cancer among young women related to prior thyroid disease and pregnancy history. Br J Cancer 1987;55:191-195.
38. McTiernan A, Weiss NS, Daling JR. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors. Am J Epidemiol 1984;120:423-435.
39. Franceschi S, Fassina A, Talamini R, et al. The influence of reproductive and hormonal factors on thyroid cancer in women. Rev Epidemiol Sante Publique 1990;38:27-34.
40. Mack WJ, Preston-Martin S, Bernstein L, Qian D, Xiang M. Reproductive and hormonal risk factors for thyroid cancer in Los Angeles County females. Cancer Epidemiol Biomarkers Prev 1999;8:991-997.
41. Memon A, Darif M, Al-Saleh K, Suresh A. Epidemiology of reproductive and hormonal factors in thyroid cancer: evidence from a case-control study in the Middle East. Int J Cancer 2002;97:82-89.
42. Kolonel LN, Hankin JH, Wilkens LR, et al. An epidemiologic study of thyroid cancer in Hawaii. Cancer Causes Control 1990;1:223-234.
43. Franceschi S, Levi F, Negri E, et al. Diet and thyroid cancer: A pooled analysis of four European case-control studies. Int J Cancer 1991;48:395-398.
44. World Health Organization, International Agency for Research on Cancer. Volume 80: Non-ionizing radiation, Part 1, Static and extremely lowfrequency (ELF) electric and magnetic fields. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 2002: Lyon, France.